Whan In Pharm Co.,Ltd.
016580.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
195
Cost of Revenue
124
Gross Profit
70
Gross Margin
36.1%
Operating Income
16
Operating Margin
8.3%
Net Income
18
Net Margin
9.0%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
25
EBITDA Margin
12.9%
2023
12/31/2023
Revenue
173
Cost of Revenue
99
Gross Profit
74
Gross Margin
42.6%
Operating Income
24
Operating Margin
14.1%
Net Income
22
Net Margin
12.9%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
30
EBITDA Margin
17.6%
2022
12/31/2022
Revenue
149
Cost of Revenue
75
Gross Profit
74
Gross Margin
49.7%
Operating Income
22
Operating Margin
15.0%
Net Income
18
Net Margin
12.0%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
26
EBITDA Margin
17.4%
2021
12/31/2021
Revenue
133
Cost of Revenue
63
Gross Profit
70
Gross Margin
52.6%
Operating Income
23
Operating Margin
17.6%
Net Income
20
Net Margin
15.0%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
29
EBITDA Margin
21.4%
2020
12/31/2020
Revenue
129
Cost of Revenue
64
Gross Profit
65
Gross Margin
50.4%
Operating Income
21
Operating Margin
16.6%
Net Income
18
Net Margin
13.6%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
26
EBITDA Margin
20.5%